Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort
- PMID: 31630877
- DOI: 10.1016/j.pathol.2019.07.008
Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort
Abstract
Autoantibodies to glycine and tryptophan-rich bodies (GWB) can be detected on routine antinuclear antibodies (ANA) testing and might have important disease associations. The aim of this study was to investigate the prevalence of anti-GWB antibodies identified on routine ANA testing, define their antigenic specificities and describe their clinical association. Anti-GWB antibodies were identified by distinct cytoplasmic staining pattern on all samples referred for ANA testing over a 6-month period. All positive anti-GWB samples were further tested on a multiplex addressable bead immunoassay (ALBIA) with known GWB antigens. Extractable nuclear antigens (ENA) were characterised by line immunoblot assay. Clinical details were collected retrospectively by contacting patients and the requesting clinicians. Eleven patients (7 females, 4 males) out of a total of 2136 positive ANAs requested on 11,265 samples had the classical GWB pattern (0.5%). The median age of patients was 66 years (range 39-92). There was no consistent disease association. Ten were confirmed to have distinct antigenic specificity for known GWB antigens. Ge-1/Hedls and RAP55 were the most common antigenic specificity targets [seen in 7 patients (64%) and in 5 patients (45%), respectively]. Ro52 was positive in 5/9 (56%) patients, SSB in 2/9 (22%) patients and Ro60 in 1/9 (11%) patient. The clinical association of anti-GWB antibodies is uncertain but might point towards autoimmune origin of certain non-specific musculoskeletal symptoms. The antigenic specificity of anti-GWB reactivity could point towards specific clinical associations: anti-RAP55 and Ge-1 in non-specific musculoskeletal conditions versus anti-GW182 in neurological diseases.
Keywords: ALBIA; ANA; Glycine and tryptophan-rich bodies; anti-GWB; autoantibodies.
Crown Copyright © 2019. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis.Clin Exp Immunol. 2011 Feb;163(2):147-56. doi: 10.1111/j.1365-2249.2010.04288.x. Epub 2010 Nov 22. Clin Exp Immunol. 2011. PMID: 21091667 Free PMC article.
-
Clinical and serological features of patients with autoantibodies to GW/P bodies.Clin Immunol. 2007 Dec;125(3):247-56. doi: 10.1016/j.clim.2007.07.016. Epub 2007 Sep 17. Clin Immunol. 2007. PMID: 17870671 Free PMC article.
-
Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein.Clin Chem Lab Med. 2020 Aug 10;59(1):197-207. doi: 10.1515/cclm-2020-0981. Clin Chem Lab Med. 2020. PMID: 32776893 Free PMC article.
-
From ANA to ENA: how to proceed?Autoimmun Rev. 2006 Jan;5(1):10-7. doi: 10.1016/j.autrev.2005.05.007. Epub 2005 Jun 13. Autoimmun Rev. 2006. PMID: 16338206 Review.
-
The Clinical Relevance of Anti-DFS70 Autoantibodies.Clin Rev Allergy Immunol. 2017 Apr;52(2):202-216. doi: 10.1007/s12016-016-8564-5. Clin Rev Allergy Immunol. 2017. PMID: 27350273 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical